CoChat

Vaccines for Women Age 50 and Older1

Open access
Gardner, Pierce, Pabbatireddy, Sudha · 2004 · Emerging Infectious Diseases
Cited by 15

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

For older populations, most of whom are women, preventing illnesses and deaths through the use of vaccines is a leading public health challenge.Our understanding about how age and sex affect the immune system is limited, and basic and translational research aimed at improving vaccines and immune responses of older persons is needed.In the meantime, fully implementing current vaccine recommendations, particularly those for influenza and pneumococcal vaccines, can save thousands of lives and prevent illnesses in persons >50 years of age.I n the United States, the elderly are more likely to die of a vaccine-preventable disease.Adult deaths from influenza (≈36,000/y) (1,2), invasive pneumococcal disease (≈9,000/y) (3), and hepatitis B (≈5,000/y) (4) exceed vaccine-preventable deaths among children (≈50/y) by a ratio of ≈1,000:1.For each of these diseases, case-fatality rates rise with increasing age.This disparity can be addressed through adult vaccination programs, which are cost-effective and life-saving.Women constitute most of the adult U.S. population >50 years of age (60% of those 75 years of age and 70% of those 85 years of age).The immune system does not function as well with advancing age (5).For example, T-cell functions diminish with age, as evidenced by the increased prevalence of anergy to mycobacterial and fungal skin-test antigens and the increased frequency and severity of herpes zoster infection with age.B-cell function diminishes, as seen with the lessened humoral response (immunoglobulin [Ig] M, IgG, and IgA) to certain vaccines (e.g., hepatitis B, influenza, pneumococcal vaccine), and the protective efficacy of these vaccines also decreases as recipients age (6,7).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3201/eid0703.040469

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 15

Metadata

Authors
Gardner, P., & Pabbatireddy, S.
Venue
Emerging Infectious Diseases
Published
2004-11
Volume
10
Issue
11
Pages
1990-1995
ISSN
  • 1080-6040 (ISSN-L)
  • 1080-6059
OpenAlex
W2087669330
Cited by
15
References
2
FWCI
0.11
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.